Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology.
Hu D, Zhang Z, Liu X, Wu Y, An Y, Wang W, Yang M, Pan Y, Qiao K, Du C, Zhao Y, Li Y, Bao J, Qin T, Pan Y, Xia Z, Zhao X, Sun K.
Hu D, et al.
J Transl Med. 2024 May 28;22(1):512. doi: 10.1186/s12967-024-05326-0.
J Transl Med. 2024.
PMID: 38807223